We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Study of Cellular Impairments Involved in Diabetic Complications (diabmito I)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2009 by Naestved Hospital.
Recruitment status was:  Active, not recruiting
ClinicalTrials.gov Identifier:
First Posted: September 28, 2009
Last Update Posted: July 27, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Naestved Hospital
The purpose of this study is to examine if an early detectable dysfunction in a cellular component (mitochondria) may predict complications in diabetes mellitus.

Diabetes Mellitus

Study Type: Observational
Study Design: Observational Model: Case Control
Official Title: Study of the Significance of Mitochondrial Dysfunction for Development of Diabetic Complications

Resource links provided by NLM:

Further study details as provided by Naestved Hospital:

Primary Outcome Measures:
  • endothelial damage [ Time Frame: 3 times pr years ]

Estimated Enrollment: 80
Study Start Date: April 2010
diabetes no complications
diabetes with complications


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
outpatient diabetes clinic Naestved Hospital, denmark

Inclusion Criteria:

  • Diabetes mellitus

Exclusion Criteria:

  • Age below 18 yrs
  • Psychiatric disease
  • Other metabolic disease
  Contacts and Locations
No Contacts or Locations Provided
  More Information

Responsible Party: Chief Physician, M.D., DMSc. Ass. prof. Jan Kvetny, Department of Internal Medicine & Faculty of Health Sciences, University of Copenhagen
ClinicalTrials.gov Identifier: NCT00985101     History of Changes
Other Study ID Numbers: SJ-109
First Submitted: September 24, 2009
First Posted: September 28, 2009
Last Update Posted: July 27, 2010
Last Verified: September 2009

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Complications
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases